Oral cancer is not a rare disease and unfortunately it is on the rise. This year approximately 45,780 people will be diagnosed with oral cancer in the United States alone. Due to late stage discovery, one american dies every hour from oral cancer.
Dr. Vatafu uses an oral cancer screening device, Oral ID, in efforts to discover oral cancers in their earliest stages. Currently 63% of oral cancers are found in late stages ( stage III, IV), resulting in 5-year survival rate of less than 50%. Finding these abnormalities in much earlier stage can increase the 5-year survival rate up to 80-90%.
Oral ID uses a proven, optically based technology called ” fluorescence technology”. Oral ID fluorescence technology uses a blue light( 435-460 nm) that provides the clinician an aid in visualization of oral mucosal abnormalities, such as oral cancer and pre-cancer. The other medical applications of fluorescence technology include highlighting abnormalities of the GI tract, cervix, lung, and skin. It is easy to use and non-threatening for patients.